Literature DB >> 21778404

Endocannabinoids: an appetite for fat.

Vincenzo Di Marzo1.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21778404      PMCID： PMC3150924          DOI： 10.1073/pnas.1109567108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

Authors:  J Simiand; M Keane; P E Keane; P Soubrié
Journal:  Behav Pharmacol       Date:  1998-03       Impact factor: 2.293

Review 2.  Endocannabinoid control of food intake and energy balance.

Authors:  Vincenzo Di Marzo; Isabel Matias
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

3.  Endocannabinoid signal in the gut controls dietary fat intake.

Authors:  Nicholas V DiPatrizio; Giuseppe Astarita; Gary Schwartz; Xiaosong Li; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

5.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

6.  Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.

Authors:  Patrice D Cani; Maite Lasa Montoya; Audrey M Neyrinck; Nathalie M Delzenne; Didier M Lambert
Journal:  Br J Nutr       Date:  2004-11       Impact factor: 3.718

7.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats.

Authors:  N Jamshidi; D A Taylor
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

8.  Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

Authors:  G Colombo; R Agabio; G Diaz; C Lobina; R Reali; G L Gessa
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3.

Authors:  Mauro Maccarrone; Marianna Di Rienzo; Alessandro Finazzi-Agrò; Antonello Rossi
Journal:  J Biol Chem       Date:  2003-01-28       Impact factor: 5.157
View more
  12 in total

Review 1.  The thrifty lipids: endocannabinoids and the neural control of energy conservation.

Authors:  Nicholas V DiPatrizio; Daniele Piomelli
Journal:  Trends Neurosci       Date:  2012-05-22       Impact factor: 13.837

2.  Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.

Authors:  A M Monteleone; V Di Marzo; P Monteleone; R Dalle Grave; T Aveta; M El Ghoch; F Piscitelli; U Volpe; S Calugi; M Maj
Journal:  Eur J Nutr       Date:  2016-01-12       Impact factor: 5.614

3.  Central (mainly) actions of GPCRs in energy homeostasis/balance: view from the Chair.

Authors:  N Gallo-Payet
Journal:  Int J Obes Suppl       Date:  2014-07-08

4.  Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling.

Authors:  Giovanna Morello; Roberta Imperatore; Letizia Palomba; Carmine Finelli; Giuseppe Labruna; Fabrizio Pasanisi; Lucia Sacchetti; Lorena Buono; Fabiana Piscitelli; Pierangelo Orlando; Vincenzo Di Marzo; Luigia Cristino
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

5.  Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences.

Authors:  Sei Higuchi; Keiichi Irie; Ryuji Yamaguchi; Mai Katsuki; Maiko Araki; Makiko Ohji; Kazuhide Hayakawa; Shohei Mishima; Yoshiharu Akitake; Kiyoshi Matsuyama; Kenji Mishima; Kenichi Mishima; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

6.  Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation.

Authors:  Bhavapriya Vaitheesvaran; Li Yang; Kirsten Hartil; Sherrye Glaser; Stephen Yazulla; James E Bruce; Irwin J Kurland
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

7.  Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors.

Authors:  Alexandros G Sykaras; Claire Demenis; R Maynard Case; John T McLaughlin; Craig P Smith
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

8.  Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.

Authors:  S G Woodhams; A Wong; D A Barrett; A J Bennett; V Chapman; S P H Alexander
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

9.  The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation.

Authors:  Marie Smith; Richard Wilson; Sally O'Brien; Cristina Tufarelli; Susan I Anderson; Saoirse Elizabeth O'Sullivan
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

Review 10.  Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.

Authors:  John M McPartland; Geoffrey W Guy; Vincenzo Di Marzo
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.